Fate Therapeutics
FATE
#9044
Rank
ยฃ93.51 M
Marketcap
ยฃ0.81
Share price
-1.82%
Change (1 day)
-56.54%
Change (1 year)

Revenue for Fate Therapeutics (FATE)

Revenue in 2025 (TTM): ยฃ5.42 Million

According to Fate Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ5.35 Million. In 2024 the company made a revenue of ยฃ10.86 Million a decrease over the revenue in the year 2023 that were of ยฃ49.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fate Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ5.42 M-50.04%
2024 ยฃ10.86 M-78.22%
2023 ยฃ49.86 M-37.35%
2022 ยฃ79.59 M92.39%
2021 ยฃ41.37 M79.41%
2020 ยฃ23.06 M183.15%
2019 ยฃ8.14 M118.11%
2018 ยฃ3.73 M22.91%
2017 ยฃ3.03 M-14.84%
2016 ยฃ3.56 M117.47%
2015 ยฃ1.64 M
2014 N/A-100%
2013 ยฃ0.58 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.81 B 33,719.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
ยฃ16.05 B 299,549.71%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ1.33 B 24,828.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
ยฃ15.66 M 192.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.01 B 37,488.62%๐Ÿ‡บ๐Ÿ‡ธ USA